Analysis of Kangmei Pharmaceutical’s Financial Restatement Behavior from the Perspective of Corporate Governance

Guanglu Xue
DOI: https://doi.org/10.1051/e3sconf/202021802016
2020-01-01
E3S Web of Conferences
Abstract:The object is Kangmei Pharmaceutical, a listed company in the pharmaceutical sector. The research is based on corporate governance, the company’s financial restatement behavior is analyzed based on the four aspects of Kangmei Pharmaceutical’s equity structure, institutional investors, independent audit institutions, media and regulatory agencies. In order to avoid Kangmei Pharmaceutical’s adjustments, several countermeasures and suggestions are put forward, and improve the corporate governance theory of the capital market.
What problem does this paper attempt to address?